Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid

Osteonecrosis of the Jaw Clinical Trial

Official title:
A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway

Status Completed

Clinical Trial Summary

A non-interventional study to assess incident rates of Osteonecrosis of the Jaw and Infections leading to hospitalization in Cancer patients treated with XGEVA™ in Sweden, Denmark and Norway.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01967160
Study type	Observational
Source	Amgen
Contact
Status	Completed
Phase
Start date	January 2, 2012
Completion date	August 5, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01666106` - Osteonecrosis of the Jaw (ONJ) Case Registry
Not yet recruiting	`NCT06419010` - Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw	N/A
Enrolling by invitation	`NCT05329558` - Local and Systemic Changes in Osteonecrosis of the Jawbone
Completed	`NCT01201330` - DPBRN Retrospective Cohort Study of Osteonecrosis of the Jaw	N/A
Completed	`NCT01130389` - CONDOR Study of Osteonecrosis of the Jaws (TMJ)	N/A
Recruiting	`NCT06457776` - Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs